MENU
HELX
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS
Franklin Genomic Advancements ETF (HELX) Ownership - Who owns Franklin Genomic Advancements ETF?
Category: @Health
Profile
Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
13647160.00
Fund Existence
almost 5 years
Turnover
32.63
Capitalization
N/A
Yield
N/A
Total Expense Ratio
N/A
Investment Style
N/A
Risk (Beta)
N/A
Fundamentals
HELX
Net Assets
13.6M
Yield
0.00
Fund Existence
almost 5 years
Total Expense Ratio
N/A
Turnover
32.63
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
N/A
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
N/A
Assets in Top Ten Holdings
4.12M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
13.6M
Fund Type
ETF
Index Fund
No
Management Fee
N/A
Modified Duration
N/A
No Load Fund
No
Number of Long Holdings
66.00
Number of Net Holdings
N/A
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
N/A
Gain YTD
-0.454
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
Franklin Templeton ETF TrustONE FRANKLIN PARKWAYSAN MATEO
Phone
N/A
Web
etf.franklintempleton.com